Evidence map›Paper›PMID 22307609›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Plasma membrane recruitment and activation of the AGC kinase Ypk1 is mediated by target of rapamycin complex 2 (TORC2) and its effector proteins Slm1 and Slm2.

Brad J Niles, Huzefa Mogri, Andrew Hill, Ariadne Vlahakis, Ted Powers

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 140 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Making PI3K superfamily enzymes run faster.Advances in biological regulation · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Anti-Journal of fungi (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Identification of Genes Promoting Growth ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Brad J NilesDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA 95616, USA.
Huzefa Mogri
Andrew Hill
Ariadne Vlahakis
Ted Powers
University of California, Davis · USUniversity of Minnesota · US

Funding

UC Davis MCB T32 Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) MentorshipT32GM007377 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI CHEDIN, FREDERIC LOUIS · 1985 to 2023
$9.9M
TOR Complex 2 and sphingolipid biosynthesis.R01GM086387 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI POWERS, TED · 2009 to 2012
$1.3M
NIGMS NIH HHS GM086387NIGMS NIH HHS R01 GM086387NIGMS NIH HHS T32 GM007377
6 · The paper itself

Abstract

The yeast AGC kinase orthologs Ypk1 and Ypk2 control several important cellular processes, including actin polarization, endocytosis, and sphingolipid metabolism. Activation of Ypk1/2 requires phosphorylation by kinases localized at the plasma membrane (PM), including the 3-phosphoinositide-dependent kinase 1 orthologs Pkh1/Pkh2 and the target of rapamycin complex 2 (TORC2). Unlike their mammalian counterparts SGK and Akt, Ypk1 and Ypk2 lack an identifiable lipid-targeting motif; therefore, how these proteins are recruited to the PM has remained elusive. To explore Ypk1/2 function, we constructed ATP analog-sensitive alleles of both kinases and monitored global changes in gene expression following their inhibition, where we observed increased expression of stress-responsive target genes controlled by Ca(2+)-dependent phosphatase calcineurin. TORC2 has been shown previously to negatively regulate calcineurin in part by phosphorylating two related proteins, Slm1 and Slm2, which associate with the PM via plextrin homology domains. We therefore investigated the relationship between Slm1 and Ypk1 and discovered that these proteins interact physically and that Slm1 recruits Ypk1 to the PM for phosphorylation by TORC2. We observed further that these steps facilitate subsequent phosphorylation of Ypk1 by Pkh1/2. Remarkably, a requirement for Slm1, can be bypassed by fusing the plextrin homology domain of Slm1 alone onto Ypk1, demonstrating that the essential function of Slm1 is largely attributable to its role in Ypk1 activation. These findings both extend the scope of cellular processes regulated by Ypk1/2 to include negative regulation of calcineurin and broaden the repertoire of mechanisms for membrane recruitment and activation of a protein kinase.

Indexed as

Carrier ProteinsCell Cycle ProteinsCell MembraneCytoskeletal ProteinsEnzyme ActivationGlycogen Synthase Kinase 3Microscopy, FluorescencePhosphatidylinositol 3-KinasesRNA-Binding ProteinsSaccharomyces cerevisiae ProteinsCarrier ProteinsCell Cycle ProteinsCytoskeletal ProteinsGlycogen Synthase Kinase 3MCK1 protein, S cerevisiaePhosphatidylinositol 3-KinasesRNA-Binding ProteinsSaccharomyces cerevisiae ProteinsSlm1 protein, S cerevisiaeSlm2 protein, S cerevisiaeTOR2 protein, S cerevisiae

Identifiers

PMID22307609
PMCPMC3277121
OpenAlexW2028726487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.